BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$2.11B |
| 2 |
Veralto
VLTO
|
+$1.29B |
| 3 |
Blackstone
BX
|
+$1.1B |
| 4 |
Extra Space Storage
EXR
|
+$964M |
| 5 |
Airbnb
ABNB
|
+$935M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$2.47B |
| 2 |
Apple
AAPL
|
+$1.51B |
| 3 |
LSI
Life Storage, Inc.
LSI
|
+$1.29B |
| 4 |
Thermo Fisher Scientific
TMO
|
+$1.09B |
| 5 |
NVIDIA
NVDA
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.98% |
| 2 | Healthcare | 13.55% |
| 3 | Financials | 11.73% |
| 4 | Consumer Discretionary | 10.27% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
iRadimed
IRMD
$1.17B
| $27.2M | ﹤0.01% |
613,673
+117,708
| +24% | +$5.47M |
|
2752
Smith & Nephew
SNN
$12.7B
| $27.2M | ﹤0.01% |
1,098,225
+92,817
| +9% | +$2.61M |
|
2753
Evolus
EOLS
$407M
| $27.2M | ﹤0.01% |
2,973,538
-21,848
| -0.7% | -$196K |
|
2754
CALL
State Street Energy Select Sector SPDR ETF
XLE
$37.6B
| $27.1M | ﹤0.01% |
+600,000
| New | +$26.3M |
|
|
AMNB
2755
DELISTED
American National Bankshares Inc
AMNB
| $27.1M | ﹤0.01% |
714,605
-46,374
| -6% | -$1.74M |
|
2756
Blue Bird Corp
BLBD
$2.43B
| $27M | ﹤0.01% |
1,262,709
+11,707
| +0.9% | +$248K |
|
|
ALPN
2757
DELISTED
Alpine Immune Sciences Inc
ALPN
| $26.9M | ﹤0.01% |
2,351,917
+70,225
| +3% | +$864K |
|
2758
NVE Corp
NVEC
$613M
| $26.9M | ﹤0.01% |
327,181
+5,883
| +2% | +$495K |
|
|
BLUE
2759
DELISTED
bluebird bio
BLUE
| $26.8M | ﹤0.01% |
441,421
+1,785
| +0.4% | +$125K |
|
2760
RLJ Lodging Trust $1.95 Series A Preferred Stock
RLJ.PRA
$323M
| $26.8M | ﹤0.01% |
1,115,606
+50,176
| +5% | +$1.21M |
|
2761
SandRidge Energy
SD
$487M
| $26.8M | ﹤0.01% |
1,711,401
+166,603
| +11% | +$2.67M |
|
2762
Xponential Fitness
XPOF
$281M
| $26.7M | ﹤0.01% |
1,722,457
+76,717
| +5% | +$1.5M |
|
2763
iShares US Small Cap Equity Factor ETF
SMLF
$4.23B
| $26.6M | ﹤0.01% |
514,933
-26,156
| -5% | -$1.42M |
|
2764
Structure Therapeutics
GPCR
$3.59B
| $26.6M | ﹤0.01% |
527,330
+132,484
| +34% | +$4.27M |
|
2765
1-800-Flowers.com
FLWS
$265M
| $26.6M | ﹤0.01% |
3,796,195
+216,625
| +6% | +$1.63M |
|
2766
Kura Sushi USA
KRUS
$598M
| $26.5M | ﹤0.01% |
401,374
+14,206
| +4% | +$1.25M |
|
|
LICY
2767
DELISTED
Li-Cycle Holdings Corp.
LICY
| $26.5M | ﹤0.01% |
934,449
-19,489
| -2% | -$779K |
|
2768
Fate Therapeutics
FATE
$303M
| $26.5M | ﹤0.01% |
12,484,490
+505,932
| +4% | +$1.68M |
|
2769
Universal Insurance Holdings
UVE
$1.23B
| $26.5M | ﹤0.01% |
1,887,388
-2,382,012
| -56% | -$33.5M |
|
2770
Boston Omaha
BOC
$438M
| $26.4M | ﹤0.01% |
1,612,685
+62,722
| +4% | +$1.13M |
|
2771
Anika Therapeutics
ANIK
$257M
| $26.4M | ﹤0.01% |
1,416,135
-1,041,998
| -42% | -$21.6M |
|
2772
Build-A-Bear
BBW
$437M
| $26.3M | ﹤0.01% |
895,120
+10,854
| +1% | +$274K |
|
2773
Levi Strauss
LEVI
$9.53B
| $26.2M | ﹤0.01% |
1,927,110
+28,460
| +1% | +$398K |
|
|
SLGC
2774
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $26.2M | ﹤0.01% |
10,948,258
-15,158
| -0.1% | -$33.6K |
|
|
CTLP
2775
DELISTED
Cantaloupe
CTLP
| $26.1M | ﹤0.01% |
4,175,164
+120,465
| +3% | +$884K |
|
Similar funds
BlackRock's Q3 2023 Portfolio in Review
As of Q3 2023, BlackRock held 5,656 positions worth $3.48T, down 4.1% from $3.63T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
BlackRock's Q3 2023 filing shows 156 new, 2,077 increased, 2,595 reduced and 210 closed positions. Its largest new stake was Veralto: 15,466,356 shares worth $1.31B. The largest sale was Johnson & Johnson, an estimated $2.47B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2023 buy was Veralto: 15,466,356 shares worth $1.31B.
- BlackRock added most to Kenvue in Q3 2023, an estimated $2.11B increase.
- BlackRock's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $2.47B.
- BlackRock fully exited Life Storage, Inc. in Q3 2023, selling an estimated $1.29B.
- BlackRock's ten largest holdings make up 22% of its $3.48T portfolio in Q3 2023.
- BlackRock opened 156 new positions and closed 210 in Q3 2023.
- BlackRock's portfolio value fell 4.1% quarter-over-quarter to $3.48T.
Based on BlackRock's 13F filing for Q3 2023, filed 13 Nov 2023.